PCV169 ACETYLSALICYLIC ACID(ASA) MONOTHERAPY FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE- AN ASSESSMENT OF THE MEDICAL BENEFIT USING THE IQWIG METHODOLOGICAL APPROACH
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74695-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)74695-7/fulltext
Title :
PCV169 ACETYLSALICYLIC ACID(ASA) MONOTHERAPY FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE- AN ASSESSMENT OF THE MEDICAL BENEFIT USING THE IQWIG METHODOLOGICAL APPROACH
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74695-7&doi=10.1016/S1098-3015(10)74695-7
First page :
Section Title :
Open access? :
No
Section Order :
623